CompoAtlas

Astaxanthin Algal Oil Emulsion

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Schizochytrium spp.

Source : En entier

Potency : 300 mg Docosahexaenoic acid

750 mgNot calculated
3,3'-dihydroxy-4,4'-diketo-bêta-carotène

Source : Haematococcus pluvialis - whole

20 mgNot calculated
3,3'-dihydroxy-4,4'-diketo-bêta-carotène

Source : Astaxanthin

20 mgNot calculated

Non-medicinal ingredients

Acide citrique, Gomme de xanthane, Acacia, Saveur, Eau purifiée, Acide sorbique, Palmitate d'ascorbyle, Lécithine, Huile de tournesol, Extrait de feuilles de stévia, d-alpha tocophérol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Cuillère à théminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of docosahexaenoic acid (DHA) for the maintenance of good health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Helps support/maintain normal brain function. Helps support cognitive health and/or brain function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Altra Health Inc.
NPN or DIN-HM
80102673
Status
Active licence
Licence date
14 July 2020
Revision date
Not provided
Form
Oral liquid, emulsion
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80102673

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Astaxanthin Algal Oil Emulsion”, https://compoatlas.com/en/supplements/canada/80102673-astaxanthin-algal-oil-emulsion, updated 14 July 2020.

Enter to analyse, Shift+Enter for a new line